Stage IV PDAC, KRAS G12D mutation, 2 prior lines of treatment, disease progression, find trials that allow for prior KRAS G12D and KRAS targeted therapies

I understand you have Stage IV pancreatic ductal adenocarcinoma with a KRAS G12D mutation, have had 2 prior lines of treatment with disease progression, and are looking for trials that allow prior KRAS G12D and KRAS targeted therapies.

Let me search for clinical trials that match your criteria:

I found 51 clinical trials that match your criteria for Stage IV pancreatic ductal adenocarcinoma with KRAS G12D mutation, allowing for prior KRAS targeted therapies.

You can click into any trial card to see additional info, such as a patient-friendly summary, the eligibility criteria, and the published data on the investigational drug.

Next steps to consider:

1. Further refine your results - I can help narrow down the options based on additional preferences.
2. Share with your healthcare provider – Discuss these trial results with your medical team (note: only trial results will be shared, not your chat history, to protect your privacy).
3. Get application support – Ask Newt Health to apply to these trials on your behalf for free.

What would you like to do next?